Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00254_DB00930> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00254_DB00930 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00254_DB00930 label "DDI between Doxycycline and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam. [drugbank_resource:DB00254_DB00930]" assertion.
- drugbank_resource:DB00254_DB00930 identifier "drugbank_resource:DB00254_DB00930" assertion.
- drugbank_resource:DB00254_DB00930 title "DDI between Doxycycline and Colesevelam - Bile acid sequestrants such as colesevelam may decrease the absorption of Tetracycline Derivatives. Monitor for decreased therapeutic effects of tetracycline derivatives if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction. The manufacturer of colesevelam suggests that drugs should be administered at least 1 hour before or 4 hours after colesevelam." assertion.